Literature DB >> 16372327

Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.

Kohsuke Uchida1, Naoya Masumori, Atsushi Takahashi, Naoki Itoh, Kazunori Kato, Robert J Matusik, Taiji Tsukamoto.   

Abstract

BACKGROUND: Although neuroendocrine (NE) cells in prostate cancer have been speculated to accelerate the growth and progression of surrounding cancer cells, the evidence is as yet inconclusive. We investigated the effect of an NE allograft (NE-10) and its cell line, NE-CS, which were established from the prostate of the LPB-Tag 12T-10 transgenic mouse, on human prostate cancer cell line LNCaP.
METHODS: The proliferation and pulmonary metastasis of LNCaP xenografts in athymic mice with and without NE-10 allografts were evaluated. Boyden chamber assay and microarray analysis were performed to investigate changes in invasion/migration and mRNA of LNCaP cells under the influence of the NE cells, respectively.
RESULTS: NE-10 did not influence the proliferation of LNCaP. The pulmonary metastasis of LNCaP with NE-10 significantly increased compared to mice without it. The NE-CS cells accelerated the in vitro invasion/migration of adenocarcinoma cells. Increased expression of mRNA of gelsolin was observed in LNCaP cells incubated with the supernatant of NE-CS cells.
CONCLUSIONS: The NE-10 allograft promotes pulmonary metastasis of subcutaneously inoculated LNCaP cells by facilitating cell invasion. Secretions from NE cells upregulate the expression of gelsolin, which is an actin-binding protein, resulting in acceleration of the migration of LNCaP cells. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16372327     DOI: 10.1002/pros.20369

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Neuroendocrine differentiation of prostate cancer.

Authors:  Zhen Li; Clark J Chen; Jason K Wang; Elaine Hsia; Wei Li; Jill Squires; Yin Sun; Jiaoti Huang
Journal:  Asian J Androl       Date:  2013-03-18       Impact factor: 3.285

2.  The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.

Authors:  Kohei Hashimoto; Yuki Kyoda; Toshiaki Tanaka; Toshihiro Maeda; Ko Kobayashi; Kohsuke Uchida; Hiroshi Kitamura; Koichi Hirata; Taiji Tsukamoto; Naoya Masumori
Journal:  Lab Invest       Date:  2015-01-12       Impact factor: 5.662

3.  Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals.

Authors:  Qiang Dang; Lei Li; Hongjun Xie; Dalin He; Jiaqi Chen; Wenbing Song; Luke S Chang; Hong-Chiang Chang; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Oncol       Date:  2015-03-05       Impact factor: 6.603

4.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

5.  Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.

Authors:  Aparna Gupta; Xiuping Yu; Tom Case; Manik Paul; Michael M Shen; Klaus H Kaestner; Robert J Matusik
Journal:  Prostate       Date:  2012-10-11       Impact factor: 4.104

6.  The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

Authors:  Ren Jie Jin; Yongsoo Lho; Linda Connelly; Yongqing Wang; Xiuping Yu; Leshana Saint Jean; Thomas C Case; Katharine Ellwood-Yen; Charles L Sawyers; Neil A Bhowmick; Timothy S Blackwell; Fiona E Yull; Robert J Matusik
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

7.  Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics.

Authors:  Andrew S Goldstein; Devon A Lawson; Donghui Cheng; Wenyi Sun; Isla P Garraway; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

8.  SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.

Authors:  Murali Gururajan; Karen A Cavassani; Margarit Sievert; Peng Duan; Jake Lichterman; Jen-Ming Huang; Bethany Smith; Sungyong You; Srinivas Nandana; Gina Chia-Yi Chu; Sheldon Mink; Sajni Josson; Chunyan Liu; Matteo Morello; Lawrence W M Jones; Jayoung Kim; Michael R Freeman; Neil Bhowmick; Haiyen E Zhau; Leland W K Chung; Edwin M Posadas
Journal:  Oncotarget       Date:  2015-12-29

9.  Neuroendocrine Cells of the Prostate Derive from the Neural Crest.

Authors:  Jaroslaw Szczyrba; Anne Niesen; Mathias Wagner; Petra M Wandernoth; Gerhard Aumüller; Gunther Wennemuth
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

Review 10.  The many faces of neuroendocrine differentiation in prostate cancer progression.

Authors:  Stéphane Terry; Himisha Beltran
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.